General form of registration statement for all companies including face-amount certificate companies

RESTATEMENT (Details 1)

v3.8.0.1
RESTATEMENT (Details 1) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2018
Feb. 28, 2017
Feb. 28, 2018
Feb. 28, 2017
Aug. 31, 2017
Aug. 31, 2016
Consolidated Statements of Operations            
Research and development [1] $ 647,467   $ 680,543      
Total Operating Expenses 798,464 [1] $ 11,995 1,075,521 [1] $ 21,512 $ 232,789 $ 29,690
Loss from Operations (798,464) [1] (11,995) (1,075,521) [1] (21,512) (232,789) (29,690)
NET LOSS (798,464) [1] (13,011) (1,075,521) [1] (22,528) (234,889) (29,690)
TOTAL COMPREHENSIVE LOSS $ (799,718) [1] $ (13,011) $ (1,077,800) [1] $ (22,528) $ (234,232) $ (29,690)
Basic and Diluted Loss per Common Share (in dollars per share) $ (0.07) [1] $ (0.00) $ (0.10) [1] $ (0.00) $ (0.03) $ (0.00)
Originally Reported            
Consolidated Statements of Operations            
Research and development $ 477,357   $ 510,433      
Total Operating Expenses 628,354   905,411      
Loss from Operations (628,354)   (905,411)      
NET LOSS (628,354)   (905,411)      
TOTAL COMPREHENSIVE LOSS $ (629,608)   $ (907,690)      
Basic and Diluted Loss per Common Share (in dollars per share) $ (0.05)   $ (0.08)      
Restatement Adjustment            
Consolidated Statements of Operations            
Research and development $ 170,110   $ 170,110      
Total Operating Expenses 170,110   170,110      
Loss from Operations (170,110)   (170,110)      
NET LOSS (170,110)   (170,110)      
TOTAL COMPREHENSIVE LOSS $ (170,110)   $ (170,110)      
Basic and Diluted Loss per Common Share (in dollars per share) $ (0.02)   $ (0.02)      
[1] Restated